Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 464

The DOI matches its Crossref record; 22 of the 22 references it cites were found in a registry or an index.

Lung Cancer Incidence and Mortality with Extended Follow-up in the National Lung Screening Trial

Open access
·2019·Journal of Thoracic Oncology

Abstract

Background The National Lung Screening Trial (NLST) randomized high-risk current and former smokers to 3 annual screens with either low-dose computed tomography (LDCT) or chest radiographs (CXR) and demonstrated a significant reduction in lung cancer mortality in the LDCT arm after median 6.5 years follow-up. We report on extended follow-up of NLST subjects. Methods Subjects were followed by linkage to state cancer registries and the National Death Index. The number needed to screen (NNS) to prevent one lung cancer death was computed as the reciprocal of the difference in the proportion dying of lung cancer across arms. Lung cancer mortality rate ratios (RRs) were computed overall and adjusted for dilution effect, the latter where only deaths with corresponding diagnosis close enough to the end of protocol screening were included. Results Median follow-up was 11.3 years for incidence and 12.3 years for mortality. 1701 and 1681 lung cancers were diagnosed in the LDCT and CXR arms, respectively; RR=1.01 (95% CI: 0.95-1.09). Observed lung cancer deaths were 1147 (LDCT) versus 1236 (CXR), RR=0.92 (95% CI: 0.85-1.00). The difference across arms in the number (per 1,000) dying of lung cancer was 3.3, translating into a NNS of 303, similar to the original NNS estimate of around 320. The dilution-adjusted lung cancer mortality RR was 0.89 (95% CI: 0.80-0.997). For overall mortality, there were 5253 (LDCT) and 5366 (CXR) deaths, for a difference across arms (per 1,000) of 4.2 (95% CI: −2.6-10.9). Conclusion Extended follow-up of the NLST showed a similar NNS as the original analysis. There was no overall increase in lung cancer incidence in the LDCT versus CXR arm.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.jtho.2019.05.044

Cites

22 of 22 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 22 references

Cited by

See all 464

Metadata

Venue
Journal of Thoracic Oncology
Publisher
Elsevier BV
Published
2019-10
Volume
14
Issue
10
Pages
1732-1742
ISSN
1556-0864 (ISSN-L)
OpenAlex
W2954417969
Cited by
464
References
22
FWCI
34.26
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Lung Cancer Incidence and Mortality with Extended Follow-up in the National Lung Screening Trial. https://app.cochat.ai/papers/10.1016/j.jtho.2019.05.044
The paper
Lung Cancer Incidence and Mortality with Extended Follow-up in the National Lung Screening Trial. (2019). Journal of Thoracic Oncology. https://doi.org/10.1016/j.jtho.2019.05.044

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.